Literature DB >> 10577922

A founder effect in the newfoundland population reduces the Bardet-Biedl syndrome I (BBS1) interval to 1 cM.

T L Young1, M O Woods, P S Parfrey, J S Green, D Hefferton, W S Davidson.   

Abstract

Bardet-Biedl syndrome (BBS) is a rare, autosomal recessive disorder; major phenotypic findings include dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal anomalies. In the majority of northern European families with BBS, the syndrome is linked to a 26-cM region on chromosome 11q13. However, the finding, so far, of five distinct BBS loci (BBS1, 1q; BBS2, 16q; BBS3, 3p; BBS4, 15q; BBS5, 2q) has hampered the positional cloning of these genes. We use linkage disequilibrium (LD) mapping in an isolated founder population in Newfoundland to significantly reduce the BBS1 critical region. Extensive haplotyping in several unrelated BBS families of English descent revealed that the affected members were homozygous for overlapping portions of a rare, disease-associated ancestral haplotype on chromosome 11q13. The LD data suggest that the BBS1 gene lies in a 1-Mb, sequence-ready region on chromosome 11q13, which should enable its identification.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10577922      PMCID: PMC1288379          DOI: 10.1086/302686

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  26 in total

1.  The importance of renal impairment in the natural history of Bardet-Biedl syndrome.

Authors:  D O'Dea; P S Parfrey; J D Harnett; D Hefferton; B C Cramer; J Green
Journal:  Am J Kidney Dis       Date:  1996-06       Impact factor: 8.860

2.  Bardet-Biedl syndrome: a molecular and phenotypic study of 18 families.

Authors:  P L Beales; A M Warner; G A Hitman; R Thakker; F A Flinter
Journal:  J Med Genet       Date:  1997-02       Impact factor: 6.318

3.  Common ancestral mutation in the MEN1 gene is likely responsible for the prolactinoma variant of MEN1 (MEN1Burin) in four kindreds from Newfoundland.

Authors:  S E Olufemi; J S Green; P Manickam; S C Guru; S K Agarwal; M B Kester; Q Dong; A L Burns; A M Spiegel; S J Marx; F S Collins; S C Chandrasekharappa
Journal:  Hum Mutat       Date:  1998       Impact factor: 4.878

4.  A 2.8-Mb clone contig of the multiple endocrine neoplasia type 1 (MEN1) region at 11q13.

Authors:  S C Guru; S E Olufemi; P Manickam; C Cummings; L M Gieser; B L Pike; M L Bittner; Y Jiang; A C Chinault; N J Nowak; A Brzozowska; J S Crabtree; Y Wang; B A Roe; J M Weisemann; M S Boguski; S K Agarwal; A L Burns; A M Spiegel; S J Marx; W L Flejter; P J de Jong; F S Collins; S C Chandrasekharappa
Journal:  Genomics       Date:  1997-06-15       Impact factor: 5.736

5.  Fine-scale genetic mapping based on linkage disequilibrium: theory and applications.

Authors:  M Xiong; S W Guo
Journal:  Am J Hum Genet       Date:  1997-06       Impact factor: 11.025

6.  Linkage mapping in 29 Bardet-Biedl syndrome families confirms loci in chromosomal regions 11q13, 15q22.3-q23, and 16q21.

Authors:  E A Bruford; R Riise; P W Teague; K Porter; K L Thomson; A T Moore; M Jay; M Warburg; A Schinzel; N Tommerup; K Tornqvist; T Rosenberg; M Patton; D C Mansfield; A F Wright
Journal:  Genomics       Date:  1997-04-01       Impact factor: 5.736

7.  A sequence-ready high-resolution physical map of the best macular dystrophy gene region in 11q12-q13.

Authors:  P R Cooper; N J Nowak; M J Higgins; S A Simpson; A Marquardt; H Stoehr; B H Weber; D S Gerhard; P J de Jong; T B Shows
Journal:  Genomics       Date:  1997-04-15       Impact factor: 5.736

8.  Eighteen new polymorphic markers in the multiple endocrine neoplasia type 1 (MEN1) region.

Authors:  P Manickam; S C Guru; L V Debelenko; S K Agarwal; S E Olufemi; J M Weisemann; M S Boguski; J S Crabtree; Y Wang; B A Roe; I A Lubensky; Z Zhuang; M B Kester; A L Burns; A M Spiegel; S J Marx; L A Liotta; M R Emmert-Buck; F S Collins; S C Chandrasekharappa
Journal:  Hum Genet       Date:  1997-11       Impact factor: 4.132

9.  Linkage disequilibrium analysis in young populations: pseudo-vitamin D-deficiency rickets and the founder effect in French Canadians.

Authors:  M Labuda; D Labuda; M Korab-Laskowska; D E Cole; E Zietkiewicz; J Weissenbach; E Popowska; E Pronicka; A W Root; F H Glorieux
Journal:  Am J Hum Genet       Date:  1996-09       Impact factor: 11.025

10.  Use of a DNA pooling strategy to identify a human obesity syndrome locus on chromosome 15.

Authors:  R Carmi; T Rokhlina; A E Kwitek-Black; K Elbedour; D Nishimura; E M Stone; V C Sheffield
Journal:  Hum Mol Genet       Date:  1995-01       Impact factor: 6.150

View more
  11 in total

1.  Identification of a novel basic helix-loop-helix-PAS factor, NXF, reveals a Sim2 competitive, positive regulatory role in dendritic-cytoskeleton modulator drebrin gene expression.

Authors:  Norihisa Ooe; Koichi Saito; Nobuyoshi Mikami; Iwao Nakatuka; Hideo Kaneko
Journal:  Mol Cell Biol       Date:  2004-01       Impact factor: 4.272

2.  Genetic structure of the Newfoundland and Labrador population: founder effects modulate variability.

Authors:  Guangju Zhai; Jiayi Zhou; Michael O Woods; Jane S Green; Patrick Parfrey; Proton Rahman; Roger C Green
Journal:  Eur J Hum Genet       Date:  2015-12-16       Impact factor: 4.246

3.  Clinical and genetic epidemiology of Bardet-Biedl syndrome in Newfoundland: a 22-year prospective, population-based, cohort study.

Authors:  Susan J Moore; Jane S Green; Yanli Fan; Ashvinder K Bhogal; Elizabeth Dicks; Bridget A Fernandez; Mark Stefanelli; Christopher Murphy; Benvon C Cramer; John C S Dean; Philip L Beales; Nicholas Katsanis; Anne S Bassett; William S Davidson; Patrick S Parfrey
Journal:  Am J Med Genet A       Date:  2005-02-01       Impact factor: 2.802

Review 4.  Bardet-Biedl Syndrome.

Authors:  Evgeny N Suspitsin; Evgeny N Imyanitov
Journal:  Mol Syndromol       Date:  2016-04-15

5.  Delineation of the critical interval of Bardet-Biedl syndrome 1 (BBS1) to a small region of 11q13, through linkage and haplotype analysis of 91 pedigrees.

Authors:  N Katsanis; R A Lewis; D W Stockton; P M Mai; L Baird; P L Beales; M Leppert; J R Lupski
Journal:  Am J Hum Genet       Date:  1999-12       Impact factor: 11.025

6.  Very high incidence of familial colorectal cancer in Newfoundland: a comparison with Ontario and 13 other population-based studies.

Authors:  R C Green; J S Green; S K Buehler; J D Robb; D Daftary; S Gallinger; J R McLaughlin; P S Parfrey; H B Younghusband
Journal:  Fam Cancer       Date:  2007       Impact factor: 2.375

7.  Genetic and mutational analyses of a large multiethnic Bardet-Biedl cohort reveal a minor involvement of BBS6 and delineate the critical intervals of other loci.

Authors:  P L Beales; N Katsanis; R A Lewis; S J Ansley; N Elcioglu; J Raza; M O Woods; J S Green; P S Parfrey; W S Davidson; J R Lupski
Journal:  Am J Hum Genet       Date:  2001-02-01       Impact factor: 11.025

8.  Linkage disequilibrium mapping in the Newfoundland population: a re-evaluation of the refinement of the Bardet-Biedl syndrome 1 critical interval.

Authors:  Yanli Fan; Jane S Green; Alison J Ross; Philip L Beales; Patrick S Parfrey; William S Davidson
Journal:  Hum Genet       Date:  2004-10-23       Impact factor: 4.132

9.  Profound, prelingual nonsyndromic deafness maps to chromosome 10q21 and is caused by a novel missense mutation in the Usher syndrome type IF gene PCDH15.

Authors:  Lance Doucette; Nancy D Merner; Sandra Cooke; Elizabeth Ives; Dante Galutira; Vanessa Walsh; Tom Walsh; Linda MacLaren; Tracey Cater; Bridget Fernandez; Jane S Green; Edward R Wilcox; Lawrence I Shotland; Larry Shotland; Xiaoyan Cindy Li; X C Li; Ming Lee; Mary-Claire King; Terry-Lynn Young
Journal:  Eur J Hum Genet       Date:  2008-12-24       Impact factor: 4.246

10.  Genetic interaction of BBS1 mutations with alleles at other BBS loci can result in non-Mendelian Bardet-Biedl syndrome.

Authors:  Philip L Beales; Jose L Badano; Alison J Ross; Stephen J Ansley; Bethan E Hoskins; Brigitta Kirsten; Charles A Mein; Philippe Froguel; Peter J Scambler; Richard Alan Lewis; James R Lupski; Nicholas Katsanis
Journal:  Am J Hum Genet       Date:  2003-04-03       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.